Buscar resultados de ensayos clínicos
Heparin-induced Thrombocytopenia - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II Condición: Heparin-induced Thrombocytopenia Type II Fecha: 2009-03-12 Intervenciones: Drug: argatroban |
Terminated |
Nombre del estudio: Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia Condición: Heparin-induced Thrombocytopenia Fecha: 2012-05-11 Intervenciones: Drug: Rivaroxaban Rivaroxaban 15 mg bid until HIT excluded by local laboratory assay or platelets recove |
Recruiting |
Nombre del estudio: Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) Condición: Heparin-induced Thrombocytopenia Fecha: 2017-05-01 Intervenciones: Drug: Warfarin, NOAC duration of treatment |
Completed |
Nombre del estudio: Heparin Induced Thrombocytopenia: Pharmacoeconomics Condición: Heparin Induced Thrombocytopenia (HIT) Fecha: 2007-04-02 |
Completed |
Nombre del estudio: Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients Condición: Heparin-induced Thrombocytopenia (HIT) Fecha: 2013-08-01 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Optimizing the Diagnosis of Heparin Induced Thrombocytopenia Condición: Heparin-induced Thrombocytopenia (HIT) Fecha: 2017-04-10 Intervenciones: Diagnostic Test: Diagnostic algorithm The treating physician will complete an enrollment assessment incl |
Completed |
Nombre del estudio: Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients Condición:
|
Terminated |
Nombre del estudio: A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome Condición: Suspected Heparin-Induced Thrombocytopenia Fecha: 2008-11-06 Intervenciones: Drug: Desirudin or Argatroban® Desirudin 15mg SC Argatroban® IV dosing per Package Insert |
Completed |
Nombre del estudio: Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) Condición:
Fecha: 2002-08-14 Intervenciones: Drug: bivalirudin Bivalirudin therapy will be given as a 0.75-mg/kg intravenous bolus and 1.75-mg/kg/h i |
Recruiting |
Nombre del estudio: Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2 Condición: Heparin-induced Thrombocytopenia Fecha: 2015-06-03 Intervenciones: Procedure: Blood Draw A one time blood draw of 150 milliliters will be performed using a vein in the par |